Elsevier Inc.

SHERPA: Unknown

People

  1. Nelson
    Nelson
  2. Mulhall
    Mulhall
  3. Thor
    Thor
  4. Vickers
    Vickers
  5. Deasy
    Deasy
  6. Gillespie
    Gillespie
  7. Robson
    Robson
  8. Powell
    Powell
  9. Zauber
    Zauber
  10. Khan
    Khan

Groups

  1. Population Sciences Research Program (1128)
  2. Survivorship Research (525)
  3. Department of Medicine (413)
  4. Epidemiology and Biostatistics (385)
  5. Surgery (380)
  6. Psychiatry and Behavioral Sciences, Department of (323)
  7. Solid Tumor Oncology Division (272)
  8. Psychiatry Service (249)
  9. Urology (194)
  10. Biostatistics Service (168)
Search Within
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (616)
  2. Meeting Abstract (402)
  3. Review (43)
  4. Editorial (23)
  5. Book Section (22)
  6. Research Letter (10)
  7. Correspondence (8)
  8. Guidelines (3)
  9. Conference Paper (1)
Groups
  1. Population Sciences Research Program (1128)
  2. Survivorship Research (525)
  3. Department of Medicine (413)
  4. Epidemiology and Biostatistics (385)
  5. Surgery (380)
  6. Psychiatry and Behavioral Sciences, Department of (323)

More Groups

People
  1. Christian Nelson (151)
  2. John Mulhall (138)
  3. Erin Gillespie (98)
  4. Maria Thor (73)
  5. Andrew Vickers (65)
  6. Joseph Deasy (58)

More People

Years
  1. 2025 (23)
  2. 2024 (87)
  3. 2023 (101)
  4. 2022 (102)
  5. 2021 (94)
  6. 2020 (85)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (202)
  2. Journal of Sexual Medicine (178)
  3. Gynecologic Oncology (58)
  4. Gastroenterology (53)
  5. Journal of Pain and Symptom Management (50)
  6. Journal of Thoracic Oncology (50)

More Publications

Results (1128)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline drivers of gynecologic carcinosarcoma
    Meeting Abstract

    Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Real-world outcomes and adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Ma, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Aghajanian, C.; Green, A.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • My individualized risk reduction for ovarian cancer (MIRROR): Development of a patient decision aid for risk-reducing surgery in hereditary risk for ovarian cancer
    Meeting Abstract

    Feinberg, J.; Gordhandas, S.; Austria, M.; Carlsson, S.; Abu-Rustum, N.; Liu, Y.; Roche, K. L.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Thirugnanasambandam, R. P.; Firestone, R.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Mailankody, S.; Lahoud, O.; Landau, H.; Chung, D.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Individualized risk in newly diagnosed multiple myeloma
    Meeting Abstract

    Maura, F.; Rajanna, A.; Ziccheddu, B.; Derkach, A.; Poos, A.; Maclachlan, K.; Boyle, E.; Hultcrantz, M.; Silva, A.; Jackson, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) vs daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C. R.; Maclachlan, K.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Patel, D.; Shekarkhand, T.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Evolving M-spike and risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Nemirovsky, D.; Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Evaluating dynamic changes in the serum free light chain ratio and its effect on risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Nemirovsky, D.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save